The DOI matches its Crossref record; 238 of the 238 references it cites were found in a registry or an index.
Type I interferons in infectious disease
Open accessAbstract
Type I interferons (IFNs) have diverse effects on innate and adaptive immune cells during infection with viruses, bacteria, parasites and fungi, directly and/or indirectly through the induction of other mediators. Type I IFNs are important for host defence against viruses. However, recently, they have been shown to cause immunopathology in some acute viral infections, such as influenza virus infection. Conversely, they can lead to immunosuppression during chronic viral infections, such as lymphocytic choriomeningitis virus infection. During bacterial infections, low levels of type I IFNs may be required at an early stage, to initiate cell-mediated immune responses. High concentrations of type I IFNs may block B cell responses or lead to the production of immunosuppressive molecules, and such concentrations also reduce the responsiveness of macrophages to activation by IFNγ, as has been shown for infections with Listeria monocytogenes and Mycobacterium tuberculosis. Recent studies in experimental models of tuberculosis have demonstrated that prostaglandin E2 and interleukin-1 inhibit type I IFN expression and its downstream effects, demonstrating that a cross-regulatory network of cytokines operates during infectious diseases to provide protection with minimum damage to the host.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“If type I IFNs are present early and properly localized to sites of infection, they can effectively limit viral propagation, as type I IFNs are responsible for optimal activation of macrophages, antigen presentation by DCs, and enhanced anti-viral effector T cell responses106.”
From SARS-CoV-2, COVID-19 and the aging immune system (2021) · cites this paper as [106]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of the microbiota in immunity and inflammation.
Belkaid, Y., & Hand, T. W. (2014) · Cell · doi:10.1016/j.cell.2014.03.011 · Cited by 5,385
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
Gerold, G., & Pietschmann, T. (2014) · Digestive Diseases · doi:10.1159/000360830 · Cited by 4,871
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
Ge, D., Fellay, J., Thompson, A. J. V., Simon, J. S., Shianna, K. V., Urban, T. J., Heinzen, E. L., Qiu, P., Bertelsen, A. H., Muir, A. J., et al. (2009) · Nature · doi:10.1038/nature08309 · Cited by 3,533
Regulation of type I interferon responses
Ivashkiv, L. B., & Donlin, L. T. (2013) · Nature reviews. Immunology · doi:10.1038/nri3581 · Cited by 3,442
Functional Role of Type I and Type II Interferons in Antiviral Defense
Müller, U., Steinhoff, U., Reis, L. F. L., Hemmi, S., Pavlovic, J., Zinkernagel, R. M., & Aguet, M. (1994) · Science · doi:10.1126/science.8009221 · Cited by 2,453
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
Thomas, D. L., Thio, C. L., Martin, M. P., Qi, Y., Ge, D., Ó’hUigín, C., Kidd, J. R., Kídd, K. K., Khakoo, S. I., Alexander, G., et al. (2009) · Nature · doi:10.1038/nature08463 · Cited by 2,147
Tanaka, Y., Nishida, N., Sugiyama, M., Kurosaki, M., Matsuura, K., Sakamoto, N., Nakagawa, M., Korenaga, M., Hino, K., Hige, S., et al. (2009) · Nature Genetics · doi:10.1038/ng.449 · Cited by 2,141
An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis
Berry, M. P. R., Graham, C. M., McNab, F. W., Xu, Z., Bloch, S. A. A., Oni, T., Wilkinson, K. A., Banchereau, R., Skinner, J., Wilkinson, R. J., et al. (2010) · Nature · doi:10.1038/nature09247 · Cited by 1,898
Self-citationInterferons, interferon‐like cytokines, and their receptors
Pestka, S., Krause, C. D., & Walter, M. R. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00204.x · Cited by 1,845
IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
Study, F. T. H. C., Suppiah, V., Moldovan, M. V., Ahlenstiel, G., Berg, T., Weltman, M., Abate, M. L., Bassendine, M. F., Spengler, U., Dore, G. J., et al. (2009) · Nature Genetics · doi:10.1038/ng.447 · Cited by 1,829
Flagged first, then by citations
Cited by
Sorted by citations
Items 701–800 of 1,004
Type I IFN Induction via Poly-ICLC Protects Mice against Cryptococcosis
Sionov, E., Mayer-Barber, K. D., Chang, Y. C., Kauffman, K. D., Eckhaus, M., Salazar, A. Μ., Barber, D. L., & Kwon-Chung, K. J. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1005040 · Cited by 34
Self-citationAuray, G., Lachance, C., Wang, Y., Gagnon, C. A., Segura, M., & Gottschalk, M. G. (2016) · PLoS ONE · doi:10.1371/journal.pone.0156019 · Cited by 33
Interferon-λs and Plasmacytoid Dendritic Cells: A Close Relationship
Finotti, G., Tamassia, N., & Cassatella, M. A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01015 · Cited by 36
DDX3 in HIV-1 infection and sensing: A paradox
Stunnenberg, M., Geijtenbeek, T. B. H., & Gringhuis, S. I. (2018) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2018.03.001 · Cited by 34
Cell type-specific function of TRAF2 and TRAF3 in regulating type I IFN induction
Xie, X., Jin, J., Zhu, L., Jie, Z., Li, Y., Zhao, B., Cheng, X., Li, P., & Sun, S. (2019) · Cell & Bioscience · doi:10.1186/s13578-018-0268-5 · Cited by 33
Huang, Y., Dai, H., & Ke, R. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01736 · Cited by 33
INEXAS: A Phase 2 Randomized Trial of On‐demand Inhaled Interferon Beta‐1a in Severe Asthmatics
McCrae, C., Olsson, M., Gustafson, P., Malmgren, A., Aurell, M., Fagerås, M., Silva, C. A. D., Cavallin, A., Paraskos, J., Karlsson, K., et al. (2020) · Clinical & Experimental Allergy · doi:10.1111/cea.13765 · Cited by 33
Lu, Z.-D., Chen, Y., Shen, S., Xu, C., & Wang, J. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c08329 · Cited by 33
Hauptstein, N., Pouyan, P., Kehrein, J., Dirauf, M., Drießen, M. D., Raschig, M., Licha, K., Gottschaldt, M., Schubert, U. S., Haag, R., et al. (2021) · Biomacromolecules · doi:10.1021/acs.biomac.1c00775 · Cited by 33
Pennemann, F. L., Mussabekova, A., Urban, C., Stukalov, A., Andersen, L. L., Grass, V., Lavacca, T. M., Holze, C., Oubraham, L., Benamrouche, Y., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-27192-w · Cited by 36
Kim, C.-U., Jeong, Y. L., Lee, P., Lee, M., Park, J., Kim, Y., & Kim, D. (2022) · Cellular and Molecular Immunology · doi:10.1038/s41423-022-00862-5 · Cited by 35
Chronic Hepatitis B Infection: New Approaches towards Cure
Ogunnaike, M., Das, S., Raut, S. S., Sultana, A., Nayan, M. U., Ganesan, M., Edagwa, B., Osna, N. A., & Poluektova, L. Y. (2023) · Biomolecules · doi:10.3390/biom13081208 · Cited by 33
Complex Regulation Pattern of IRF3 Activation Revealed by a Novel Dimerization Reporter System
Wang, Z., Ji, J., Peng, D., Ma, F., Cheng, G., & Qin, F. X.-F. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502458 · Cited by 34
Hassanzadeh‐Kiabi, N., Yáñez, A., Dang, I., Martins, G. A., Underhill, D. M., & Goodridge, H. S. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1601143 · Cited by 33
Guan, X., Zhang, M., Fu, M., Luo, S., & Hu, Q. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00290 · Cited by 33
TRIMming Type I Interferon-Mediated Innate Immune Response in Antiviral and Antitumor Defense
Wang, L., & Ning, S. (2021) · Viruses · doi:10.3390/v13020279 · Cited by 34
Locke, M. C., Fox, L. E., Dunlap, B. F., Young, A. R., Monte, K. J., & Lenschow, D. J. (2021) · Journal of Virology · doi:10.1128/jvi.01143-21 · Cited by 32
Reovirus Activated Cell Death Pathways
DeAntoneo, C., Danthi, P., & Balachandran, S. (2022) · Cells · doi:10.3390/cells11111757 · Cited by 34
Mihăescu, G., Chifiriuc, M. C., Filip, R., Bleoţu, C., Diţu, L.-M., Constantin, M., Cristian, R.-E., Grigore, R., Bertesteanu, S. V., Berteșteanu, G. S., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1273604 · Cited by 34
Park, H.-E., Park, H.-T., Jung, Y. H., & Yoo, H. S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196502 · Cited by 39
Medie, F. M., Sharma‐Kuinkel, B. K., Ruffin, F., Chan, L. C., Rossetti, M. M., Chang, Y., Park, L. P., Bayer, A. S., Filler, S. G., Ahn, R. S., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1909849116 · Cited by 34
mRNA-Based Vaccines and Mode of Action
Gergen, J., & Petsch, B. (2020) · Current topics in microbiology and immunology · doi:10.1007/82_2020_230 · Cited by 36
NMI Facilitates Influenza A Virus Infection by Promoting Degradation of IRF7 through TRIM21
Ouyang, W., Cen, M., Yang, L., Zhang, W., Xia, J., & Xu, F. (2021) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2020-0391oc · Cited by 32
Perumal, P., Abdullatif, M. B., Garlant, H. N., Honeyborne, I., Lipman, M. C. I., McHugh, T. D., Southern, J., Breen, R. A. M., Santis, G., Ellappan, K., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.612564 · Cited by 32
Barrila, J., Sarker, S. F., Hansmeier, N., Yang, S., Buss, K., Briones, N., Park, J. K., Davis, R. R., Forsyth, R. J., Ott, C. M., et al. (2021) · npj Microgravity · doi:10.1038/s41526-021-00136-w · Cited by 34
García-del-Barco, D., Risco-Acevedo, D., Berlanga‐Acosta, J., Martos-Benítez, F. D., & Guillén, G. E. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.655528 · Cited by 32
Interferon Signaling in Estrogen Receptor–positive Breast Cancer: A Revitalized Topic
Fu, X., Angelis, C. D., & Schiff, R. (2021) · Endocrinology · doi:10.1210/endocr/bqab235 · Cited by 33
Replication and Spread of Oncolytic Herpes Simplex Virus in Solid Tumors
Hong, B., Sahu, U., Mullarkey, M. P., & Kaur, B. (2022) · Viruses · doi:10.3390/v14010118 · Cited by 33
Pont, G. C. D., Lee, A., Bortoluzzi, C., Farnell, Y. Z., Gougoulias, C., & Kogut, M. H. (2022) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2022.104524 · Cited by 32
Zhu, W., Zhang, Y., Liao, Z., Huo, X., Yang, C., Zhang, Y., & Su, J. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2200787 · Cited by 32
Wan, S., Ashraf, U., Ye, J., Duan, X., Zohaib, A., Wang, W., Chen, Z., Zhu, B., Li, Y., Chen, H., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12395 · Cited by 32
Min, C.-K., Kim, H.-I., Ha, N., Kim, Y., Kwon, E.-K., Yen, N. T. H., Youn, J., Jeon, Y. K., Inn, K., Choi, M., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02022 · Cited by 32
Type I interferon signaling in malignant blasts contributes to treatment efficacy in AML patients
Holíček, P., Truxová, I., Raková, J., Šálek, C., Hensler, M., Kovář, M., Reiniš, M., Mikyšková, R., Pasulka, J., Vosahlikova, S., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05728-w · Cited by 31
Type I interferons drive MAIT cell functions against bacterial pneumonia
López‐Rodríguez, J. C., Hancock, S. J., Li, K., Crotta, S., Barrington, C., Suárez‐Bonnet, A., Priestnall, S. L., Aubé, J., Wack, A., Klenerman, P., et al. (2023) · The Journal of Experimental Medicine · doi:10.1084/jem.20230037 · Cited by 33
Self-citationCD5L as a promising biological therapeutic for treating sepsis
Oliveira, L., Silva, M., Gomes, A., Santos, R. F., Cardoso, M. S., Nóvoa, A., Luche, H., Cavadas, B., Amorim, I., Gärtner, F., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48360-8 · Cited by 31
Kurmasheva, N., Said, A., Wong, B., Kinderman, P., Han, X., Rahimic, A. H. F., Kress, A., Carter-Timofte, M. E., Holm, E., van der Horst, D., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48422-x · Cited by 31
Chi, X., Huang, G., Wang, L., Zhang, X., Liu, J., Yin, Z., Guo, G., Chen, Y., Wang, S., & Chen, J. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012461 · Cited by 31
de, M. M., Good, M. F., McCarthy, J. S., & Engwerda, C. R. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600619 · Cited by 31
Silva, M. R., Aguilar-Briseño, J. A., Upasani, V., van der Ende-Metselaar, H. H., Smit, J. M., & Rodenhuis‐Zybert, I. A. (2017) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0005712 · Cited by 31
French, M. A., Tjiam, M. C., Abudulai, L. N., & Fernández, S. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00780 · Cited by 31
The Dynamic Interplay between HIV-1, SAMHD1, and the Innate Antiviral Response
Antonucci, J. M., Gelais, C. S., & Wu, L. J. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01541 · Cited by 33
How the Respiratory Epithelium Senses and Reacts to Influenza Virus
Benam, K. H., Denney, L., & Ho, L. (2018) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2018-0247tr · Cited by 33
Cheng, Q. J., Behzadi, F., Sen, S., Ohta, S., Spreafico, R., Teles, R. M. B., Modlin, R. L., & Hoffmann, A. (2019) · Scientific Reports · doi:10.1038/s41598-019-40503-y · Cited by 31
Hu, X., Peng, X., Lu, C., Zhang, X., Gan, L., Gao, Y., Yang, S., Xu, W., Wang, J., Yin, Y., et al. (2019) · FEBS Journal · doi:10.1111/febs.15001 · Cited by 31
Wang, W., Chong, W. P., Li, C., Chen, Z., Wu, S., Zhou, H., Wan, Y., Chen, W., Gery, I., Liu, Y., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.06.021 · Cited by 31
Alexander, M. R., Brice, A. M., van Vuren, P. J., Rootes, C. L., Tribolet, L., Cowled, C. J., Bean, A. G. D., & Stewart, C. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073392 · Cited by 32
Jin, J., Meng, X., Huo, Y., & Deng, H. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03989-x · Cited by 31
TYK2 in Cancer Metastases: Genomic and Proteomic Discovery
Borcherding, D. C., He, K., Amin, N. V., & Hirbe, A. C. (2021) · Cancers · doi:10.3390/cancers13164171 · Cited by 31
Inhibition of IRGM establishes a robust antiviral immune state to restrict pathogenic viruses
Nath, P., Chauhan, N. R., Jena, K. K., Datey, A., Kumar, N. D., Mehto, S., De, S., Nayak, T. K., Priyadarsini, S., Rout, K., et al. (2021) · EMBO Reports · doi:10.15252/embr.202152948 · Cited by 31
Adenosine-to-inosine RNA editing contributes to type I interferon responses in systemic sclerosis
Vlachogiannis, N. I., Tual‐Chalot, S., Zormpas, E., Bonini, F., Ntouros, P. A., Pappa, M. B., Bournia, V.-K., Tektonidou, M. G., Souliotis, V. L., Mavragani, C. P., et al. (2021) · Journal of Autoimmunity · doi:10.1016/j.jaut.2021.102755 · Cited by 31
Sankaradoss, A., Jagtap, S., Nazir, J., Moula, S. E., Modak, A., Fialho, J., Iyer, M., Shastri, J. S., Dias, M., Gadepalli, R., et al. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.01.013 · Cited by 31
Intracellular mono-ADP-ribosyltransferases at the host–virus interphase
Lüscher, B., Verheirstraeten, M., Krieg, S., & Korn, P. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04290-6 · Cited by 33
Pyronaridine Protects against SARS-CoV-2 Infection in Mouse
Puhl, A. C., Gomes, G. F., Damasceno, S., Godoy, A. S., Noske, G. D., Nakamura, A. M., Gawriljuk, V. O., Fernandes, R. S., Monakhova, N., Riabova, O., et al. (2022) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.2c00091 · Cited by 32
Mu, W., Rezek, V. K., Martin, H. A., Carrillo, M. A., Tomer, S., Hamid, P., Lizarraga, M. A., Tibbe, T. D., Yang, O. O., Jamieson, B. D., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.159136 · Cited by 31
Hepatocyte-Specific Deletion of Mouse Lamin A/C Leads to Male-Selective Steatohepatitis
Kwan, R., Brady, G. F., Brzozowski, M., Weerasinghe, S. V. W., Martin, H., Park, M.-J., Brunt, M. J., Menon, R. K., Tong, X., Yin, L., et al. (2017) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2017.06.005 · Cited by 31
TYK2 in Tumor Immunosurveillance
Karjalainen, A., Shoebridge, S., Krunic, M., Simonović, N., Tebb, G., Macho‐Maschler, S., Strobl, B., & Müller, M. M. (2020) · Cancers · doi:10.3390/cancers12010150 · Cited by 31
Virus Infection and Systemic Inflammation: Lessons Learnt from COVID-19 and Beyond
Faist, A., Janowski, J., Kumar, S., Hinse, S., Çalışkan, D. M., Lange, J., Ludwig, S., & Brunotte, L. (2022) · Cells · doi:10.3390/cells11142198 · Cited by 31
How robust are estimates of key parameters in standard viral dynamic models?
Zitzmann, C., Ke, R., Ribeiro, R. M., & Perelson, A. S. (2024) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1011437 · Cited by 30
Bachur, R. G., Kaplan, S. L., Arias, C. A., Ballard, N., Carroll, K. C., Cruz, A. T., Gordon, R. D., Halabi, S., Harris, J. D., Hultén, K. G., et al. (2024) · Journal of the American College of Emergency Physicians Open · doi:10.1002/emp2.13167 · Cited by 30
SP140–RESIST pathway regulates interferon mRNA stability and antiviral immunity
Witt, K. C., Dziulko, A., An, J., Pekovic, F., Cheng, A. X., Liu, G. Y., Lee, O. V., Turner, D. J., Lari, A., Gaidt, M. M., et al. (2025) · Nature · doi:10.1038/s41586-025-09152-2 · Cited by 30
Down regulation of macrophage IFNGR1 exacerbates systemic L. monocytogenes infection
Eshleman, E. M., Delgado, C., Kearney, S. J., Friedman, R. S., & Lenz, L. L. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006388 · Cited by 30
Oh, D. S., Oh, J. E., Jung, H. E., & Lee, H. K. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00819 · Cited by 30
Ardanuy, J., Scanlon, K. M., Skerry, C. M., Fuchs, S. Y., & Carbonetti, N. H. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1900912 · Cited by 30
Zhang, M., Fu, M., Li, M., Hu, H., Gong, S., & Hu, Q. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000418 · Cited by 30
Interferon therapy for COVID-19 and emerging infections: Prospects and concerns
Calabrese, L. H., Lenfant, T., & Calabrese, C. M. (2020) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.87a.ccc066 · Cited by 31
microRNA-induced translational control of antiviral immunity by the cap-binding protein 4EHP
Zhang, X., Chapat, C., Wang, P., Choi, J., Li, Q., Luo, J., Wiebe, S. A., Kim, S., Robichaud, N., Karam, I. F., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.01.030 · Cited by 30
Sun, W., Liu, S., Huang, X., Yuan, R., & Yu, J. (2021) · Royal Society Open Science · doi:10.1098/rsos.210296 · Cited by 30
Lin, C.-Y., Shih, M.-C., Chang, H.-C., Lin, K.-J., Chen, L.-F., Huang, S.-W., Yang, M.-L., Ma, S.-K., Shiau, A., Wang, J., et al. (2021) · Journal of Biomedical Science · doi:10.1186/s12929-021-00764-0 · Cited by 30
Levels of Influenza A Virus Defective Viral Genomes Determine Pathogenesis in the BALB/c Mouse Model
Penn, R., Tregoning, J. S., Flight, K. E., Baillon, L., Frise, R., Goldhill, D. H., Johansson, C., & Barclay, W. (2022) · Journal of Virology · doi:10.1128/jvi.01178-22 · Cited by 30
Martins, I. C., Ricardo, R. C., & Santos, N. C. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14112535 · Cited by 34
Song, L., Wang, D., Abbas, G., Li, M., Cui, M., Wang, J., Lin, Z., & Zhang, X. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.102990 · Cited by 31
IDH1 mutation impairs antiviral response and potentiates oncolytic virotherapy in glioma
Chen, X., Liu, J., Li, Y., Zeng, Y., Wang, F., Cheng, Z., Duan, H., Pan, G., Yang, S., Chen, Y., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-42545-3 · Cited by 30
Negative regulation of type I IFN signaling by phosphorylation of STAT2 on T387
Wang, Y., Jing, N., Willard, B. B., Wang, X., Yang, J. B., & Stark, G. R. (2016) · The EMBO Journal · doi:10.15252/embj.201694834 · Cited by 30
Luo, K., Zhang, S., Tang, D., Xia, L., Gao, W., Tian, G., Qi, Z., Xu, Q., & Zhang, W. (2018) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2018.03.011 · Cited by 30
Takaoka, A., & Yamada, T. (2019) · International Immunology · doi:10.1093/intimm/dxz034 · Cited by 33
Ivanova, E. N., Shwetar, J., Devlin, J. C., Buus, T. B., Gray-Gaillard, S. L., Koide, A., Cornelius, A. R., Samanovic, M. I., Herrera, A. M., Mimitou, E. P., et al. (2021) · medRxiv · doi:10.1101/2021.04.20.21255677 · Cited by 29
Arthur, C. M., Allen, J. W. L., Verkerke, H., Yoo, J., Jajosky, R. P., Girard‐Pierce, K. R., Chonat, S., Zerra, P. E., Maier, C. L., Rha, J., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020002695 · Cited by 29
Emerging cellular themes in leukodystrophies
Nowacki, J. C., Fields, A. M., & Fu, M. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.902261 · Cited by 29
Moinuddin, A., Poznanski, S. M., Portillo, A. L., Monteiro, J. K., & Ashkar, A. A. (2024) · Immunological Reviews · doi:10.1111/imr.13316 · Cited by 29
Zika virus: from an obscurity to a priority
Lee, C. Y., & Ng, L. F. P. (2018) · Microbes and Infection · doi:10.1016/j.micinf.2018.02.009 · Cited by 31
Sugrue, J. A., Bourke, N. M., & O’Farrelly, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.757249 · Cited by 30
Xiong, W., He, W., Wang, T., He, S., Xu, F., Wang, Z., Wang, X., Guo, H., Ling, J., Zhang, H., et al. (2022) · Advanced Science · doi:10.1002/advs.202103029 · Cited by 29
Colarusso, C., Terlizzi, M., Maglio, A., Molino, A., Candia, C., Vitale, C., Hansbro, P. M., Vatrella, A., Pinto, A., & Sorrentino, R. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.934264 · Cited by 29
Regulation of innate immune responses by rabies virus
Zhang, H., Huang, J., Song, Y., Liu, X., Qian, M., Huang, P., Li, Y., Zhao, L., & Wang, H. (2022) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12273 · Cited by 29
Molecular Mechanisms in the Vascular and Nervous Systems following Traumatic Spinal Cord Injury
Li, S., Dinh, H. T. P., Matsuyama, Y., Sato, K., & Yamagishi, S. (2022) · Life · doi:10.3390/life13010009 · Cited by 34
Liu, Z., Chao, J., Wang, C., Sun, G., Roeth, D., Liu, W., Chen, X., Li, L., Tian, E., Feng, L., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112841 · Cited by 30
Patton, M. J., McCorrister, S. J., Grant, C., Westmacott, G., Fariss, R. N., Hu, P., Zhao, K., Blake, M., Whitmire, B., Yang, C., et al. (2016) · mBio · doi:10.1128/mbio.01427-16 · Cited by 29
Feng, N., Zhou, Z., Li, Y., Zhao, L., Xue, Z., Lu, R., & Jia, K. (2017) · Virus Research · doi:10.1016/j.virusres.2017.05.008 · Cited by 29
Pellefigues, C., Tang, S., Schmidt, A., White, R. F., Lamiable, O., Connor, L. M., Ruedl, C., Dobrucki, J. W., Gros, G. S. L., & Ronchese, F. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01575 · Cited by 29
Influenza A Virus Induces Autophagosomal Targeting of Ribosomal Proteins
Becker, A. C., Gannagé, M., Giese, S., Hu, Z., Abou-Eid, S., Roubaty, C., Paul, P., Bühler, L., Gretzmeier, C., Dumit, V. I., et al. (2018) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra117.000364 · Cited by 29
Goulding, L., Yang, J., Jiang, Z., Zhang, H., Lea, D., Emes, R. D., Dottorini, T., Pu, J., Liu, J., & Chang, K. (2020) · Viruses · doi:10.3390/v12101093 · Cited by 29
Type I interferon regulation by USP18 is a key vulnerability in cancer
Jové, V., Wheeler, H., Lee, C. W., Healy, D. R., Levine, K. K., Ralph, E. C., Yamaguchi, M., Jiang, Z. K., Cabral, E., Xu, Y., et al. (2024) · iScience · doi:10.1016/j.isci.2024.109593 · Cited by 30
A human commensal-pathogenic fungus suppresses host immunity via targeting TBK1
Luo, G., Zhang, J., Wang, T., Cui, H., Bai, Y., Luo, J., Zhang, J., Zhang, M., Di, L., Yuan, Y., et al. (2024) · Cell Host & Microbe · doi:10.1016/j.chom.2024.07.003 · Cited by 29
Type I IFN drives neutrophil swarming, impeding lung T cell–macrophage interactions and TB control
Branchett, W. J., Stavropoulos, E., Shields, J. M., Al‐Dibouni, A., Cardoso, M. S., Fernandes, A. I., Moreira-Teixeira, L., Slawinski, H., Mikolajczak, A., Rodgers, A., et al. (2025) · The Journal of Experimental Medicine · doi:10.1084/jem.20250466 · Cited by 28
Self-citationAdipose type I interferon signalling protects against metabolic dysfunction
Adolph, T. E., Wieser, V. E., Grander, C., Grabherr, F., Enrich, B., Moser, P. L., Moschen, A. R., Kaser, S., & Tilg, H. (2017) · Journal of Hepatology · doi:10.1016/s0168-8278(17)31656-2 · Cited by 28
Plasma Type I IFN Protein Concentrations in Human Tuberculosis
Llibre, A., Bilek, N., Bondet, V., Darboe, F., Mbandi, S. K., Penn‐Nicholson, A., Hatherill, M., Rozenberg, F., Scriba, T. J., & Duffy, D. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00296 · Cited by 28
Zhang, L., Li, W., Sun, Y., Kong, L., Xu, P., Xia, P., & Zhang, G. (2020) · Viruses · doi:10.3390/v12020187 · Cited by 28
Type I Interferon in Children with Viral or Bacterial Infections
Trouillet‐Assant, S., Viel, S., Ouziel, A., Boisselier, L., Rebaud, P., Basmaci, R., Droz, N., Bélot, A., Pons, S., Brengel‐Pesce, K., et al. (2020) · Clinical Chemistry · doi:10.1093/clinchem/hvaa089 · Cited by 28
Infection and cancer suppress pDC derived IFN-I
Greene, T. T., Jo, Y., & Zúñiga, E. I. (2020) · Current Opinion in Immunology · doi:10.1016/j.coi.2020.08.001 · Cited by 28
New onset systemic lupus erythematosus after COVID-19 infection: a case report
Ramachandran, L., Dontaraju, V. S., Troyer, J., & Sahota, J. (2022) · AME Case Reports · doi:10.21037/acr-21-55 · Cited by 28
Metadata
- Authors
- McNab, F., Mayer-Barber, K., Sher, A., Wack, A., & O'Garra, A.
- Affiliations
- GlaxoSmithKline (United Kingdom) (GB)
- National Institutes of Health (US)
- National Institute for Medical Research (GB)
- Venue
- Nature Reviews Immunology
- Published
- 2015-01-23
- Volume
- 15
- Issue
- 2
- Pages
- 87-103
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- PMC
- PMC7162685
- OpenAlex
- W2091129202
- Cited by
- 2,780
- References
- 238
- Citations by year
- 2026: 263 · 2025: 333 · 2024: 364 · 2023: 330 · 2022: 330 · 2021: 307 · 2020: 194 · 2019: 160 · 2018: 166 · 2017: 169 · 2016: 119 · 2015: 44
- FWCI
- 15.67
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Wellcome Trust (FC001126)
- Francis Crick Institute (10206, 10126)
- Cancer Research UK (FC001126)
- National Institutes of Health
- Medical Research Council (U117597139, U117565642)
- National Institute of Allergy and Infectious Diseases
- FP7 Ideas: European Research Council (294682)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Keywords
- type I interferon, innate immunity, viral infection, bacterial infection, parasitic infection, fungal infection, immunopathology, influenza virus, lymphocytic choriomeningitis virus, chronic viral infection, immunosuppression, B cell response, macrophage activation, Listeria monocytogenes, Mycobacterium tuberculosis, prostaglandin E2, interleukin-1, host defense
- MeSH terms
- Animals, Bacterial Infections, Communicable Diseases, Humans, Interferon Type I, Mycoses, Parasitic Diseases, Virus Diseases, Signal Transduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
